Can-GARD/CCMG – The Leading Strand Series

Loading Events

This series is for genetics health professionals led by the Canadian College of Medical Genetics and co-sponsored by Can-GARD. Speakers will be translation-focused researchers, clinicians and innovators.  The series will help attendees anticipate, access, and apply new approaches and technologies for patient care.


As of March 2024, the Can-GARD/CCMG Leading Strand Series is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada.

Note, to obtain credit for this CPD activity, you must keep track of the seminars attended.  An easy way to do this is to download and save the certificate for each seminar attended which is available through the evaluation link sent after the seminar to attendees.  A letter at the end of the year will NOT be sent.



Genetic Medicine For Rare Neurogenetic Disease

In this presentation, I will summarize the current state of the field of genetic medicine approaches for neurogenetic disease. I will focus on gene therapy, and talk about its advantages and challenges.

Learning objectives:

  • Identify the benefits and challenges of gene therapy for neurogenetic disease.
  • Assess the emerging genetic medicine approaches for treating neurogenetic conditions.

Dr. Jim Dowling


Dr. Jim Dowling is a staff clinician and senior scientist at the Hospital for Sick Children and a Professor of Paediatrics and Molecular Genetics at the University of Toronto. He is also the Mogford Campbell Family Chair of Paediatric Neuroscience. Dr. Dowling received his BSc and MSc from Yale University, his MD/PhD from the University of Chicago, and did his residency in child neurology at Children’s Hospital of Philadelphia.

Dr. Dowling’s clinical expertise is in childhood neurogenetic disorders. His research examines questions of disease pathogenesis and therapy development for congenital muscle diseases. In addition to his research program, he currently serves as board chair of TREAT NMD, as an executive board member of the World Muscle Society, and as the pediatric lead of the NMD4C pan-Canadian neuromuscular network. He was recently honored to receive the Researcher of the Year Award from Muscular Dystrophy Canada.

Friday, September 29, 2023
Friday, October 27, 2023 – cancelled
Friday, November 24, 2023
Friday, December 15, 2023 @ 12:30pm – 1:30pm ET
Friday, January 26, 2024
Friday, February 23, 2024
Friday, March 22, 2024
Friday, April 26, 2024
Friday, May 31, 2024
Friday, June 28, 2024

Go to Top